1. Interleukin-21 Is Associated with Early Antiviral Response in Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis B and Nonalcoholic Fatty Liver Disease
   Xudong Liu et al, 2016, Journal of Interferon & Cytokine Research CrossRef
2. Elevated serum A20 is associated with severity of chronic hepatitis B and A20 inhibits NF-κB-mediated inflammatory response
   Hanchen Xu et al, 2017, Oncotarget CrossRef
3. Elevation of BSF-2 Level in Serum of Patients with Hepatitis B Virus
   Ali A. Dawood et al, 2021, Med. immunol. CrossRef
4. Serum Interleukins as Potential Prognostic Biomarkers in HBV-Related Acute-on-Chronic Liver Failure
   Lili Zhang et al, 2022, Mediators of Inflammation CrossRef
5. NAFLD and HBV interplay - related mechanisms underlying liver disease progression
   Evanthia Tourkochristou et al, 2022, Front. Immunol. CrossRef
6. Identification of the novel 3′ UTR sequences of human IL-21 mRNA as potential targets of miRNAs
   Yutaka Enomoto et al, 2017, Sci Rep CrossRef
7. Cytokine profiles and virological markers highlight distinctive immune statuses, and effectivenesses and limitations of NAs across different courses of chronic HBV infection
   Lixin Xiao et al, 2024, Cytokine CrossRef
8. Interleukin-21 receptor signaling promotes metabolic dysfunction-associated steatohepatitis-driven hepatocellular carcinoma by inducing immunosuppressive IgA+ B cells
   Ying Xie et al, 2024, Mol Cancer CrossRef
9. Review of the potential value of serum interleukin levels as prognostic biomarkers of liver failure
   Yong Lin et al, 2024, World J Clin Cases CrossRef